ChemAxon Introduces Marvin Live for Real-time Web Based Chemistry Collaboration

BUDAPEST, Hungary, January 20, 2015 /PRNewswire/ --

Talking chemistry for a global research team

ChemAxon today launches Marvin Live, a web based collaboration tool and meeting assistant to enable real time structure design for distributed research groups.

Marvin Live integrates ChemAxon's Marvin JS chemistry editor, structure based calculations, web services and smart report generation to give researchers a sharable space where they can sketch and modify chemical structures, see predicted properties or other available data on the structure and contribute through comments. The entire session can be output as a meeting report which includes all chemistry and comments in a searchable form and the meeting itself can persist and be extended in subsequent meetings as the project evolves.

Marvin Live is being presented at The Molecular Medicine Tri Conference 2015, February 15th-20th in San Francisco, CA and is also introduced at a free webinar on Wednesday, February 17^th at 10am EST, register at the signup page. To find out more about Marvin Live and request a demo or evaluation please visit the product page.

About ChemAxon 

ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries.  With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions that power modern cheminformatics and chemical communication.  The company is privately owned with European headquarters in Budapest, US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America.

SOURCE ChemAxon

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED